论文部分内容阅读
自1994年11月～1996年12月，采用榄香烯乳治疗老年晚期癌症36例，并用参麦液、干扰素针、参莲胶囊治疗16例作为对照，以比较二组疗效、毒副作用。榄香烯组36例中，好转11例（30．6％），稳定15例（41．7％），恶化10例（27．8％）。对照组好转5例（31．3％），稳定6例（37．5％），恶化5例（31．3％）。毒副作用主要表现为注射局部疼痛13例（36．1％），注射局部水肿6例（16．7％），发热4例（11．1％）。对照组发热8例（50％），皮疹3例（18．8％）。二组疗效接近。经统计学处理，X2＝0.344，P＜0．05。二者有差异，示榄香烯乳疗效优于对照组。二组均未观察到由药物引起外周血白细胞减少及肝、肾功能异常和心电图改变。
From November 1994 to December 1996, 36 patients with advanced stage cancer were treated with elemene milk, and 16 patients were treated with Shenmaiye, interferon-negative needles and Shenlian capsules as controls to compare the efficacy and side effects of the two groups. In the 36 cases of elemene group, 11 cases (30.6%) improved, 15 cases (41.7%) stabilized, and 10 cases (27.8%) deteriorated. The control group improved in 5 cases (31.3%), stabilized in 6 cases (37.5%), and deteriorated in 5 cases (31.3%). The main side effects of poisoning were local injection of pain in 13 cases (36.1%), injection of local edema in 6 cases (16.7%), and fever in 4 cases (11.1%). The control group had 8 cases of fever (50%) and 3 cases of rash (18.8%). The efficacy of the two groups was similar. After statistical analysis, X2=0.344, P<0.05. There was a difference between the two, indicating that the efficacy of elemene milk was superior to that of the control group. No decrease in peripheral blood leukocytes, abnormal liver and kidney function, and electrocardiogram were observed in both groups.